Prince Pharmaceutical Co Ltd banner

Intrinsic Value

Not Available for Prince Pharmaceutical Co Ltd

There is not enough data to reliably calculate the intrinsic value for Prince Pharmaceutical Co Ltd.

Do our valuations actually work? See backtest results .

Alternatives to Prince Pharmaceutical Co Ltd

Fundamental Analysis

What Prince Pharmaceutical Does

Pharmaceuticals Health Care

Prince Pharmaceutical Co. Ltd. principally engages in the production of active pharmaceutical ingredients of Vitamin B1. The company is headquartered in Huwei, Yunlin and currently employs 216 full-time employees. The company went IPO on 2023-03-29. The firm's main business is divided into ingredients business and health food business. The ingredients business currently consists of phlegm dispelling agents, vitamin B1 derivatives, and non-steroidal anti-inflammatory drugs.

Headquarters
Taiwan TW
Employees
216
IPO date
Mar 29, 2023
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue Research

Decided on Prince Pharmaceutical? Get an email when Prince Pharmaceutical Co Ltd reaches the price you’d buy at. Free with an account.

Back to Top